Skip to content
10-K

Annual Report

Fortress Biotech, Inc. FBIO FBIOP

0001104659-26-037874

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 27.9M sh
Shares Diluted FY 2025 · Dec 31, 2024 20.78M sh
Dividends Paid FY 2025 · Dec 31, 2025 $664K
Dividends Paid FY 2025 · Dec 31, 2024 $694K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$65.78M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$80.19M
Cash And Equivalents FY 2025 · Dec 31, 2025 $79.38M
Cash And Equivalents FY 2025 · Dec 31, 2024 $57.26M
Stockholders Equity FY 2025 · Dec 31, 2025 $49.87M
Stockholders Equity FY 2025 · Dec 31, 2024 $22.74M
Current Liabilities FY 2025 · Dec 31, 2025 $49.74M
Current Liabilities FY 2025 · Dec 31, 2024 $71.4M
Total Liabilities FY 2025 · Dec 31, 2025 $123.37M
Total Liabilities FY 2025 · Dec 31, 2024 $145.87M
Current Assets FY 2025 · Dec 31, 2025 $123.84M
Current Assets FY 2025 · Dec 31, 2024 $90.37M
Total Assets FY 2025 · Dec 31, 2025 $185.55M
Total Assets FY 2025 · Dec 31, 2024 $144.22M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.07
Eps Diluted FY 2025 · Dec 31, 2024 −$2.69
Eps Basic FY 2025 · Dec 31, 2025 −$0.07
Eps Basic FY 2025 · Dec 31, 2024 −$2.69
Sga Expense FY 2025 · Dec 31, 2025 $96.4M
Sga Expense FY 2025 · Dec 31, 2024 $87.73M
Net Income FY 2025 · Dec 31, 2025 $6.82M
Net Income FY 2025 · Dec 31, 2024 −$46M
Operating Income FY 2025 · Dec 31, 2025 −$70.22M
Operating Income FY 2025 · Dec 31, 2024 −$110.38M
Cost Of Revenue FY 2025 · Dec 31, 2025 $20.92M
Cost Of Revenue FY 2025 · Dec 31, 2024 $20.88M
Revenue FY 2025 · Dec 31, 2025 $63.26M
Revenue FY 2025 · Dec 31, 2024 $57.68M